Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Eosinophilic Granulomatosis With Polyangiitis Clinical Trials

3 recruiting trials for Eosinophilic Granulomatosis With Polyangiitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06046222

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

This study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis.

Sponsor: NS Pharma, Inc.Enrolling: 4520 locations
RECRUITINGNCT00315380

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the...

Sponsor: University of PennsylvaniaEnrolling: 70013 locations
RECRUITINGPhase 2 / Phase 3NCT05979051

A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis...

This study is a phase 2/3 clinical trial to evaluate the efficacy and safety of SHR-1703 in patients with EGPA.

Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 1662 locations